The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply

G. Umberto Meduri; George Chrousos; Yaseen M. Arabi

doi:10.1007/s00134-020-06335-5

Editorial Material2020

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

Yaseen M. Arabi, George Chrousos, G. Umberto Meduri

Article2022

The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Grigoris Gerotziafas, Patrick Van Dreden, Douglas D. Fraser, Guillaume Voiriot, Maitray A. Patel, Mark Daley, Alexandre Elabbadi, Aurélie Rousseau, Yannis Prassas, Matthieu Turpin, Marina Marchetti, Loula Papageorgiou, Evangelos Terpos, Meletios A Dimopoulos, Anna Falanga, Jawed Fareed, Muriel Fartoukh, Ismaı̈l Elalamy

Article2024

Modest versus significant excess mortality due to COVID-19 deaths in Europe – authors' reply

Margherita Pizzato, Alberto Giovanni Gerli, Carlo La Vecchia, Gianfranco Alicandro

Preprint2020

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio L. Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, C. Hidalgo, Geydi Lorenzo, Meylán Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet

Preprint2020

An Anti-CD6 Monoclonal Antibody (Itolizumab) Reduces Circulating IL-6 in Severe Covid-19 Elderly Patients